Efficacy and safety of intracoronary injection of recombinant human prourokinase in patients with slow blood flow/no-reflow during PCI for acute coronary syndrome: a randomised controlled, double-blind, placebo controlled, national multicentre clinical study protocol (PUK-ACS study). [PDF]
BMJ OpenLv W, Ye Y, Xie X, Zhang Y, Wang J.
europepmc +1 more source
Seeing the Small to Prevent the Big: The Role of Cerebral Microvessels in Ischemic Stroke Etiology and Prevention. [PDF]
Stroke Res TreatChan KTJ.
europepmc +1 more source
Comparative Performance of HALP, PNI, and CONUT Scores in No-Reflow Among Patients with Acute Coronary Syndrome: A Prospective Study. [PDF]
J Clin MedSavcilioglu MD +4 more
europepmc +1 more source
Predictive Ability of the CHA2DS2-VA Score for No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI. [PDF]
Clin CardiolSun Y +7 more
europepmc +1 more source
Clinical and Angiographic Predictors of No-Reflow and Its Impact on Outcomes in ST-Elevation Myocardial Infarction: A Retrospective Study. [PDF]
Clin CardiolBashir H +3 more
europepmc +1 more source
No-reflow phenomenon after primary percutaneous coronary intervention: To reflow or not to reflow?
Research in Cardiovascular Medicine, 2017 Turgay Celik +3 more
openaire +1 more source
Nanoscale Roughness in Ultra-Thick Resists by Laser-Scanning Grayscale Direct-Write Lithography and Surface Smoothing. [PDF]
Polymers (Basel)Malvicini G +4 more
europepmc +1 more source
Association Between the Atherogenic Index of Plasma and the Occurrence of Slow Flow/No-Reflow in Patients With Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention. [PDF]
Cardiol Res PractSun Q +6 more
europepmc +1 more source
Reply: No-Reflow During Primary PCI: Pharmacology Over Delivery. [PDF]
JACC AdvOliveri F +4 more
europepmc +1 more source
Inflammation-Based C-Reactive Protein-to-Albumin Ratio for No-Reflow Prediction in STEMI. [PDF]
BiomedicinesKrasniqi X +5 more
europepmc +1 more source